333 related articles for article (PubMed ID: 19220753)
1. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis.
Braden B; Caspary W; Börner N; Vinson B; Schneider AR
Neurogastroenterol Motil; 2009 Jun; 21(6):632-8, e25. PubMed ID: 19220753
[TBL] [Abstract][Full Text] [Related]
2. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
Rösch W; Vinson B; Sassin I
Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
[TBL] [Abstract][Full Text] [Related]
3. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
[TBL] [Abstract][Full Text] [Related]
4. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
Talley NJ; Verlinden M; Geenen DJ; Hogan RB; Riff D; McCallum RW; Mack RJ
Gut; 2001 Sep; 49(3):395-401. PubMed ID: 11511562
[TBL] [Abstract][Full Text] [Related]
5. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.
Zhang CL; Geng CH; Yang ZW; Li YL; Tong LQ; Gao P; Gao YQ
World J Gastroenterol; 2016 May; 22(18):4585-93. PubMed ID: 27182168
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
[TBL] [Abstract][Full Text] [Related]
7. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.
Arts J; Caenepeel P; Verbeke K; Tack J
Gut; 2005 Apr; 54(4):455-60. PubMed ID: 15753526
[TBL] [Abstract][Full Text] [Related]
8. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying].
Portincasa P; Mearin F; Robert M; Plazas MJ; Mas M; Heras J
Gastroenterol Hepatol; 2009 Dec; 32(10):669-76. PubMed ID: 19819042
[TBL] [Abstract][Full Text] [Related]
10. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study.
von Arnim U; Peitz U; Vinson B; Gundermann KJ; Malfertheiner P
Am J Gastroenterol; 2007 Jun; 102(6):1268-75. PubMed ID: 17531013
[TBL] [Abstract][Full Text] [Related]
11. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis.
Mansi C; Savarino V; Vigneri S; Perilli D; Melga P; Sciabà L; De Martini D; Mela GS
Am J Gastroenterol; 1995 Nov; 90(11):1989-93. PubMed ID: 7485007
[TBL] [Abstract][Full Text] [Related]
12. Gastroparesis: separate entity or just a part of dyspepsia?
Stanghellini V; Tack J
Gut; 2014 Dec; 63(12):1972-8. PubMed ID: 25260920
[TBL] [Abstract][Full Text] [Related]
13. New developments in the treatment of gastroparesis and functional dyspepsia.
Tack J; Camilleri M
Curr Opin Pharmacol; 2018 Dec; 43():111-117. PubMed ID: 30245474
[TBL] [Abstract][Full Text] [Related]
14. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
[TBL] [Abstract][Full Text] [Related]
15. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial.
Talley NJ; Verlinden M; Snape W; Beker JA; Ducrotte P; Dettmer A; Brinkhoff H; Eaker E; Ohning G; Miner PB; Mathias JR; Fumagalli I; Staessen D; Mack RJ
Aliment Pharmacol Ther; 2000 Dec; 14(12):1653-61. PubMed ID: 11121915
[TBL] [Abstract][Full Text] [Related]
16. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
McCallum RW; Cynshi O;
Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
[TBL] [Abstract][Full Text] [Related]
18. Long-term cisapride treatment improves diabetic gastroparesis but not glycaemic control.
Braden B; Enghofer M; Schaub M; Usadel KH; Caspary WF; Lembcke B
Aliment Pharmacol Ther; 2002 Jul; 16(7):1341-6. PubMed ID: 12144585
[TBL] [Abstract][Full Text] [Related]
19. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics.
Dutta U; Padhy AK; Ahuja V; Sharma MP
Trop Gastroenterol; 1999; 20(3):116-9. PubMed ID: 10695417
[TBL] [Abstract][Full Text] [Related]
20. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
